| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A convenient and practical index for predicting the induction response in adult patients with hemophagocytic lymphohistiocytosis: ferritin/platelet ratio
|
Feng, Cuicui
|
|
|
103 |
3 |
p. 715-723
|
article
|
| 2 |
Acute erythroid leukemia with TP53 mutation and BCR/ABL1: challenges in classification and management
|
Marra, John Donald
|
|
|
103 |
3 |
p. 1013-1014
|
article
|
| 3 |
Acute liver injury after SARS-CoV-2 vaccination and luspatercept administration in a patient with β-thalassemia
|
Leoni, Simona
|
|
|
103 |
3 |
p. 1025-1026
|
article
|
| 4 |
A different perspective on PET/CT before treatment in patients with Hodgkin lymphoma: importance of volumetric and dissemination parameters
|
Aksu, Ayşegül
|
|
|
103 |
3 |
p. 813-822
|
article
|
| 5 |
A multicentre ambispective observational study into the incidence and clinical management of aplastic anaemia in Spain (IMAS study)
|
Vallejo, Carlos
|
|
|
103 |
3 |
p. 705-713
|
article
|
| 6 |
Appropriate timing to perform an interim 18F-FDG PET/CT in patients with nasal-type extranodal natural killer/T cell lymphoma
|
Wang, Rang
|
|
|
103 |
3 |
p. 885-892
|
article
|
| 7 |
Clinical characteristics and outcomes of Epstein-Barr virus viral load after allogeneic hematopoietic stem cell transplantation
|
Tsushima, Takafumi
|
|
|
103 |
3 |
p. 935-946
|
article
|
| 8 |
Clinical characteristics of SARS-CoV-2 Omicron variant infection in children with acute leukemia
|
Huang, Pengli
|
|
|
103 |
3 |
p. 729-736
|
article
|
| 9 |
Clinical significance and predictive risk factors for event-free survival at 24 months in patients with PTCL, NOS
|
Cao, Zheng
|
|
|
103 |
3 |
p. 869-883
|
article
|
| 10 |
Comprehensive analysis of orbital lymphoma in a Turkish cohort: clinical characteristics, histological subtypes, treatment modalities, prognostic factors, and implications for management
|
Akyildiz, Arif
|
|
|
103 |
3 |
p. 905-915
|
article
|
| 11 |
CXC chemokine ligand 13 and galectin-9 plasma levels collaboratively provide prediction of disease activity and progression-free survival in chronic lymphocytic leukemia
|
Ahmed, Heba A.
|
|
|
103 |
3 |
p. 781-792
|
article
|
| 12 |
Diamond-Blackfan anemia with very late and fatal onset aplasia in a 55-year-old patient with RPL11 mutation
|
Strasser, Bernhard
|
|
|
103 |
3 |
p. 1011-1012
|
article
|
| 13 |
Diffuse large B cell lymphoma characteristics and outcomes during the COVID-19 pandemic in two tertiary centers - an Israeli/ Italian study
|
Giladi, Odil
|
|
|
103 |
3 |
p. 803-811
|
article
|
| 14 |
Effectiveness of tixagevimab/cilgavimab in patients with hematological malignancies as a pre-exposure prophylaxis to prevent severe COVID-19: a Czech retrospective multicenter study
|
Demel, Ivo
|
|
|
103 |
3 |
p. 981-992
|
article
|
| 15 |
Effect of low skeletal muscle mass on NK cells in patients with acute myeloid leukemia and its correlation with prognosis
|
Cui, Jialin
|
|
|
103 |
3 |
p. 771-780
|
article
|
| 16 |
Efficacy and safety of biosimilar Peg-filgrastim after autologous stem cell transplant in myeloma and lymphoma patients: a comparative study with biosimilar Filgrastim, Lenograstim, and originator Peg-filgrastim
|
Marchesi, Francesco
|
|
|
103 |
3 |
p. 947-956
|
article
|
| 17 |
Efficacy and safety of generic pomalidomide plus low-dose dexamethasone in relapsed or refractory multiple myeloma: a multicenter, open-label, single-arm trial
|
Zhou, Huixing
|
|
|
103 |
3 |
p. 855-868
|
article
|
| 18 |
Evaluation of the cachexia index using a bioelectrical impedance analysis in elderly patients with non-Hodgkin’s lymphoma: A single-center prospective study
|
Okubo, So
|
|
|
103 |
3 |
p. 823-831
|
article
|
| 19 |
Genomic classification and outcomes of young patients with polycythemia vera and essential thrombocythemia according to the presence of splanchnic vein thrombosis and its chronology
|
Garrote, Marta
|
|
|
103 |
3 |
p. 737-747
|
article
|
| 20 |
Heavily pretreated patient with nodal marginal zone lymphoma successfully treated with mosunetuzumab
|
Lucijanic, Marko
|
|
|
103 |
3 |
p. 1015-1016
|
article
|
| 21 |
Hypomethylating agent monotherapy in core binding factor acute myeloid leukemia: a French multicentric retrospective study
|
Gabellier, Ludovic
|
|
|
103 |
3 |
p. 759-769
|
article
|
| 22 |
Largest comparison between onset and relapses of acquired thrombotic thrombocytopenic purpura reveals severe neurological involvement and worse analytic parameters at debut
|
Vegas Villalmanzo, Blanca
|
|
|
103 |
3 |
p. 725-727
|
article
|
| 23 |
Low-dose venetoclax combined with azacitidine for blastic plasmacytoid dendritic cell neoplasm: a case report and literature review
|
Wang, Qiuyan
|
|
|
103 |
3 |
p. 999-1005
|
article
|
| 24 |
Midostaurin for FLT3-mutated AML: a real-world analysis of effectiveness and infection risk at a single center
|
Kennedy, Alice
|
|
|
103 |
3 |
p. 1031-1033
|
article
|
| 25 |
Modified EASIX scores predict severe CRS/ICANS in patients with acute myeloid leukemia following CLL1 CAR-T cell therapy
|
Zhao, Yifan
|
|
|
103 |
3 |
p. 969-980
|
article
|
| 26 |
NOTCH pathway mutation contributes to inferior prognosis in HBV-infected chronic lymphocytic leukemia
|
Shang, Chun-Yu
|
|
|
103 |
3 |
p. 833-841
|
article
|
| 27 |
Optimal dosage of rituximab for children with Burkitt lymphoma
|
Huang, Shuang
|
|
|
103 |
3 |
p. 893-903
|
article
|
| 28 |
Philadelphia chromosome-positive B cell acute lymphoblastic phase arising 24 years after treatment-free remission for chronic myeloid leukemia with identical BCR-ABL fusion transcript
|
Dereme, Julien
|
|
|
103 |
3 |
p. 1027-1029
|
article
|
| 29 |
Prognostic factors in patients with secondary hemophagocytic lymphohistioc ytosis in a Chinese cohort
|
Pei, Yuanyuan
|
|
|
103 |
3 |
p. 695-703
|
article
|
| 30 |
Reduced-intensity allogenic transplantation for children and adolescents with Philadelphia chromosome-positive acute lymphoblastic leukemia
|
Ishida, Hisashi
|
|
|
103 |
3 |
p. 843-854
|
article
|
| 31 |
Refractory hemophagocytic lymphohistiocytosis secondary to polatuzumab vedotin plus rituximab and bendamustine
|
Lv, Kebing
|
|
|
103 |
3 |
p. 1017-1019
|
article
|
| 32 |
Relapse and transformation to myelodysplastic syndrome and acute myeloid leukemia following immunosuppressive therapy for aplastic anemia is more common as compared to allogeneic stem cell transplantation with a negative impact on survival
|
Chattopadhyay, Sohini
|
|
|
103 |
3 |
p. 749-758
|
article
|
| 33 |
Small lymphocytic lymphoma infiltrating gastrointestinal tract and mimicking inflammatory bowel disease, successfully treated with acalabrutinib
|
Krečak, Ivan
|
|
|
103 |
3 |
p. 1021-1023
|
article
|
| 34 |
Temporal trends in critical care utilization and outcomes in allogeneic hematopoietic stem cell transplant recipients
|
Heybati, Kiyan
|
|
|
103 |
3 |
p. 957-967
|
article
|
| 35 |
The indirect effects of CMV reactivation on patients following allogeneic hematopoietic stem cell transplantation: an evidence mapping
|
Wu, Xiaojin
|
|
|
103 |
3 |
p. 917-933
|
article
|
| 36 |
Tislelizumab monotherapy in patients with previously untreated early-stage classical Hodgkin lymphoma: a real-world study
|
Sun, Peng
|
|
|
103 |
3 |
p. 793-801
|
article
|
| 37 |
VEXAS syndrome: complete molecular remission after hypomethylating therapy
|
Sockel, Katja
|
|
|
103 |
3 |
p. 993-997
|
article
|
| 38 |
Warm autoimmune hemolytic anemia associated with SARS-CoV-2 infection responsive to eculizumab
|
Gong, Yuemin
|
|
|
103 |
3 |
p. 1007-1009
|
article
|
Journal description